Author: Roger A. Johns, MD, PhD ASA Monitor October 2023, Vol. 87, 1–6. This isn’t FAER’s first time discussing the importance of advocacy in anesthesiology research. To help shed more light on this topic, it’s my pleasure to share a recent conversation between ASA Chief Advocacy Officer (CAO) Manuel Bonilla, FAER President James C. Eisenach, MD, […]
Read MoreAuthors: Ashish Agrawal, MD et al ASA Monitor October 2023, Vol. 87, 35. Delirium is likely the most well-known perioperative cognitive disorder. Delirium, an acute and fluctuating alteration in the level of consciousness and attention, has significant consequences for patients, families, and the health care system. The incidence of delirium is associated with increased mortality, cognitive […]
Read MoreAuthors: Chelsea Casey, MD et al ASA Monitor October 2023, Vol. 87, 20–22. Optiflow™ multi-use nasal high flow system. Reproduced with permission from Fisher and Paykel Healthcare. High-flow nasal oxygen (HFNO) is a promising new oxygenation technique for anesthesiologists, as its use in recent years has expanded out of intensive care units and into the perioperative […]
Read MoreASA Monitor October 2023, Vol. 87, 12–13. New synthetic antibiotic compound Gram-negative bacteria such as Salmonella and E. coli are responsible for many harmful infections such as UTIs, pneumonia, and bloodstream infections. Unfortunately, gram-negative bacteria are resistant to most available antibiotic drugs and continue to grow increasingly resistant to available treatments. A decades-long project at Duke University is combatting gram-negative […]
Read MoreASA Monitor October 2023, Vol. 87, 11. Your next patient will receive a dural puncture epidural for labor. According to a recent study, which of the following is MOST likely to be lower in this patient, compared with a similar patient receiving lumbar epidural anesthesia without dural puncture? □ (A) Risk of postdural puncture headache □ (B) Need […]
Read More